along with the se-(data not shown). Therefore, the cytoplasmic tail region of HLA-C is responsible for its resistance to downregulaquences of HLA-E and CD1d. The site where the cytoplasmic tails were swapped to create the chimeras is tion by HIV.
In contrast to the results with the HLA-Cw4/A2 shown by the arrow above the class I consensus sequence. Five residues of HLA-C are different from the and -Cw4/B27 chimeras, transfer of the HLA-E transmembrane and cytoplasmic tail region to HLA-Cw4 consensus sequence beyond this point (indicated by dark circles, Table 1 To define the residues that were critical for allowing HLA-A and -B downregulation, point mutations were regulation. HLA-A2 and -Cw4 chimeras containing only the cytoplasmic tails of HLA-E (A2/E-tail and Cw4/E-tail) made in the -Cw4/B27-tail chimeric molecule. Since we were interested in the residues in HLA-C that account also did not undergo Nef-dependent downregulation ). An S 35 release assay established that these NK cells (called NK.NKIR1) had mutants that contained both C321Y and N328D were downregulated. Mutants that did not contain both the the predicted specificity for class I proteins. Second, we used an immortalized cell line that we genetically tyrosine and aspartic acid were not downregulated (Figures 3E-3J ). Therefore, both Tyr-321 and Asp-328 are altered to have a defined killing specificity. Prior work (Wagtmann et al., 1995) had shown that the killing specicritical for Nef-dependent class I downregulation.
HLA-E contains both Tyr-321 and Asp-328, yet chimeficity of immortalized NK cells could be changed by transferring in genes coding for NK inhibitory receptors. ras containing the cytoplasmic tail region of HLA-E were not downregulated by HIV ( Figures 2E and 2F) . However, However, because vaccinia virus was used as the viral vector, the infected NK cells lived only transiently. We HLA-E differs from the cytoplasmic tail consensus sequence at a number of other residues, (Table 1) ., 1992) , MSCV-neo, and pBABE-puro were an amphotropic retrovirus carrying the mouse ecotropic receptor. used as described (Ausubel et al., 1996) except that the MSCV Subsequently, genes could be introduced into these 221 cells with vector was modified so that it contained no BamHI site. The mouse high efficiency using the less hazardous murine retrovirus. Approxiecotropic receptor was digested out of the pM5-neo vector and mately 1 week after infecting 221 cells with the ecotropic receptor, ligated into the pBABE-puro vector to create the vector pBABEthese cells were infected with a murine virus carrying the pBABEecotropic receptor-puro. The puromycin resistance gene was then CD4-puro construct. CD4-positive 221 cells were selected in purodeleted from this vector to create the vector pBABE-ecotropic remycin and sorted by FACS for CD4 expression. These cells were ceptor without a drug selection marker. then infected with retroviruses carrying defined class I genes. Class The genes for human CD8␣ and the class I alleles HLA-A201, I MHC-positive 221 cells were selected in neomycin and bulk sorted -B2705, -Cw304, and -Cw401 were cloned into the MSCV-neo vecby FACS for class I expression. This scheme for making CD4 and tor. Human CD4 was cloned into the pBABE-puro retrovirus vector.
class I-positive 221 cells was followed for all cell lines generated The NKIR1 gene was cloned into the vector pBABE-puro that had during the course of this work with the following exceptions: HLAbeen modified so that expression of the Sa pac gene that confers Cw702, -B702, -Cw6(C321Y) and CD1d. The genes for these class puromycin resistance was driven off of the retroviral LTR. A CMV I alleles were introduced into 221 cells by electroporation as prepromoter driving expression of the NKIR1 gene was then inserted viously described (Mandelboim et al., 1996). immediately downstream of the Sa pac gene. This vector was also C1R and YTS cells carrying the CD4 and NKIR1 genes, respecused to drive expression of the HLA-A2 leader/E construct that tively, were generated using retroviral vectors in a procedure similar contained the HLA-A2 leader (residues Met-(Ϫ24) to Ala-(Ϫ1)) joined to the one outlined above for 221 cells. to the mature HLA-E molecule (Gly-1 to Leu-337).
Class I MHC chimeric molecules containing the extracellular and transmembrane (Tm) portion of Cw4 and the cytoplasmic tail of HIV Infection, NK Assays, and Flow Cytometry HIV was generated from transfected 293 cells and HIV infection of either HLA-A1, -A2, -B15, -B27, or HLA-E were made as follows. PCR was used to introduce a BamHI site in the cytoplasmic tail of target cells was done as described previously . NK assays were performed 35-45 hr post HIV infection. 221 target HLA-Cw4 at residues 319 and 320. The BamHI restriction sequence, GGA TCC, introduces a silent mutation into Cw4 as it encodes for cells (1 ϫ 10 4 to 4 ϫ 10 4 ) were mixed with NK effector cells (at the effector to target cell ratios indicated in the text) and incubated the amino acids, Gly-319 and Ser-320, found in virtually all class I proteins. This modified -Cw4 was cloned into the EcoRI-XhoI site together in a U-bottomed 96-well microtiter plate at 37ЊC for 0-6 hr.
